Press release
Glaucoma Competitive Landscape Report (Updated) | Santen Pharmaceuticals, Visiox Pharma, Nicox Ophthalmics, pH Pharma, Omikron Italia, Tarsier Pharma, AbbVie, and others.
Glaucoma Competitive Landscape
Key Takeaways from the Glaucoma Competitive Landscape Report
• DelveInsight's Glaucoma report depicts a robust space with 45+ Glaucoma companies working to develop 50+ pipeline therapies for Glaucoma treatment.
• The leading Glaucoma Companies working in the market include Santen Pharmaceuticals, Visiox Pharma, Nicox Ophthalmics, pH Pharma, Omikron Italia, Tarsier Pharma, TearClear, Laboratoires Thea, EMS, Peregrine Ophthalmic, Ocuphire Pharma, HK inno.N, VivaVision Biotech, Qlaris Bio, Future Medicine, PolyActiva Pty Ltd, Theratocular Biotek, Whitecap Biosciences, JeniVision, AbbVie, Noveome Biotherapeutics, and others.
• Promising Glaucoma therapies in the various stages of development include rhNGF, Aflibercept (Eylea, BAY 86-5321), OPA-6566, Latanoprost, TO-O-1001, ONL1204 Ophthalmic solution (Dose A), and others.
• December 2023: Laboratorios Sophia S.A de C.V. announced a study of Phase 3 clinical trials for PRO-122, Timolol eye drops, Dorzolamide-Timolol Ophthalmic and Krytantek. A Non-inferiority in the Intraocular Pressure Decrease of the Preservative-free Ophthalmic Solution PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma.
Request a sample and discover the recent advances in Glaucoma Drugs @ Glaucoma Competitive Landscape Report- https://www.delveinsight.com/report-store/glaucoma-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
The Glaucoma report provides in-depth commercial assessment of drugs that have been included, which comprises collaboration, agreement, licensing and acquisition - deals values trends. The sub-segmentation is described in the Glaucoma report which provide company-company collaboration (licensing/partnering), company academic collaboration and acquisition analysis in tabulated form.
Glaucoma Overview
Glaucoma describes a group of conditions in which there is characteristic cupping of the optic disc with corresponding visual field defects due to retinal ganglion cell loss. It is a progressive condition and the most common cause of irreversible blindness worldwide. The two major categories of glaucoma are open-angle glaucoma and narrow-angle glaucoma/angle-closure glaucoma. The "angle" in both cases refers to the drainage angle inside the eye that controls the outflow of the watery fluid (aqueous) which is being produced inside the eye.
Find out more about Glaucoma Analytical Perspective: In-depth Commercial Assessment @ Glaucoma Collaboration Analysis by Companies- https://www.delveinsight.com/sample-request/glaucoma-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Glaucoma Companies and Therapies
• Allergan: DURYSTA
• Sun Pharma Advanced Research Company Limited: XELPROS
• Nicox Ophthalmics: NCX 470
• Tarsier Pharma: TRS01
• Qlaris Bio: QLS-101
• Noveome Biotherapeutics: ST266
Glaucoma Competitive Landscape
The Glaucoma report comprises of comparative assessment of Companies (by therapy, development stage, and technology).
Glaucoma Report Assessment
• Company Analysis
• Glaucoma Therapeutic Assessment
• Glaucoma Pipeline Assessment
• Inactive Glaucoma Drugs Assessment
• Glaucoma Unmet Needs
Learn more about the emerging Glaucoma Competitive Landscape @ Glaucoma Market Drivers and Barriers, Unmet Needs- https://www.delveinsight.com/sample-request/glaucoma-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Glaucoma Competitive Landscape Report
• Coverage- Global
• Glaucoma Companies- Santen Pharmaceuticals, Visiox Pharma, Nicox Ophthalmics, pH Pharma, Omikron Italia, Tarsier Pharma, TearClear, Laboratoires Thea, EMS, Peregrine Ophthalmic, Ocuphire Pharma, HK inno.N, VivaVision Biotech, Qlaris Bio, Future Medicine, PolyActiva Pty Ltd, Theratocular Biotek, Whitecap Biosciences, JeniVision, AbbVie, Noveome Biotherapeutics, and others.
• Glaucoma therapies- rhNGF, Aflibercept (Eylea, BAY 86-5321), OPA-6566, Latanoprost, TO-O-1001, ONL1204 Ophthalmic solution (Dose A), and others.
• Glaucoma Therapeutics Assessment- Product Type, Stage and Product Type, Route of Administration, Stage and Route of Administration, Molecule Type, Stage and Molecule Type
Dive deep into rich insights for new drugs for Glaucoma Product Developmental Activities, Visit @ Glaucoma Research and Development Activities- https://www.delveinsight.com/sample-request/glaucoma-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. Glaucoma: Overview
4. Glaucoma -Analytical Perspective: In-depth Commercial Assessment
5. Competitive Landscape
6. Therapeutic Assessment
7. Glaucoma: Company and Product Profiles (Marketed Therapies)
8. Allergan
9. DURYSTA
10. Glaucoma: Company and Product Profiles (Pipeline Therapies)
11. Late Stage Products (Phase III)
12. Nicox Ophthalmics
13. NCX 470
14. Drug profiles in the detailed report…..
15. Mid Stage Products (Phase II)
16. Qlaris Bio
17. QLS-101
18. Drug profiles in the detailed report…..
19. Early Stage Products (Phase I)
20. Noveome Biotherapeutics
21. ST266
22. Drug profiles in the detailed report…..
23. Preclinical and Discovery Stage Products
24. Company Name
25. Product Name
26. Drug profiles in the detailed report…..
27. Inactive Products
28. Glaucoma- Unmet needs
29. Glaucoma Market drivers and barriers
30. Appendix
For further information on the Glaucoma Report @ Glaucoma Preclinical and Discovery Stage Products- https://www.delveinsight.com/sample-request/glaucoma-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
List of Important Published Links
https://quantummemoir.mn.co/members/21285995
https://rightbusinesspath.mn.co/posts/48636294
https://tennispassion.mn.co/posts/48636354
https://king-business.mn.co/posts/48636411
https://forums.mbclub.co.uk/members/dennydones99.180319/#about
https://www.creativelive.com/student/dennydones1?via=accounts-freeform_2
https://tl.net/forum/profile.php?user=dennydones99
https://minne.com/@dennydones99/profile
https://network-79379.mn.co/members/20103624
https://ylimun.mn.co/members/20103614
https://kktix.com/user/5068280
https://network-373.mn.co/posts/48353213
https://body-imagine.mn.co/posts/48353364
https://pimpmyairgun.mn.co/posts/48353478
https://gtribe.mn.co/posts/advancements-and-opportunities-in-the-vulvar-cancer-market
https://communenour.mn.co/posts/emerging-trends-and-market-dynamics-in-vulvar-cancer-treatment
https://synkretic.mn.co/posts/understanding-the-vulvar-cancer-market-trends-challenges-and-innovations
https://jlfa2020.mn.co/members/16644457
https://dbook.mn.co/posts/48401881
https://lxgonline.mn.co/posts/navigating-the-landscape-of-hypertriglyceridemia-market-current-trends-and-future-prospects
https://www.penname.me/@dennydones99
https://community.fyers.in/member/7Yldtdsvui
https://spurstartup.mn.co/posts/48406045
https://pressurecooker.mn.co/posts/48406225
https://regenerative-future.mn.co/posts/navigating-the-hypertriglyceridemia-market-innovations-and-challenges
https://commiss.io/dennydones
https://www.pledgeme.co.nz/profiles/221820/
https://brave-comfort.mn.co/posts/48409148
https://gamebook.mn.co/posts/navigating-the-landscape-of-the-hypertriglyceridemia-market
https://biomolecula.ru/authors/25303
https://discuss.machform.com/u/dennydones9191
https://dagshub.com/dennydones9191
https://careerkarma.com/profile/clr7d7z0c04v2lf3k5lrx9vyr/
https://gotech.mn.co/posts/48477911
https://landmarknew.mn.co/posts/48477947
https://infiniteabundance.mn.co/posts/48478016
https://wellbeingmatters.mn.co/posts/48478424
https://vrjam.mn.co/posts/48478544
https://decidim.santcugat.cat/profiles/dennydones9/activity
https://haveagood.holiday/users/336105
https://participa.rubi.cat/profiles/dennydones9191/activity
https://forum.callofwar.com/index.php?user/60304-dennydones9191/#about
https://connectgalaxy.com/post/146081_syphilis-a-sexually-transmitted-bacterial-infection-caused-by-treponema-pallidum.html
https://www.thebostoncalendar.com/user/74833
https://wrongplanet.net/author/dennydones9999/
https://bookmark.hiauthors.com/story/syphilis-market
https://www.openhumans.org/member/anniethomas/
https://cynochat.com/read-blog/160375
https://hitrecord.org/users/dennydones9999/records
https://biiut.com/read-blog/918
https://nimmansocial.com/story5840956/syphilis-market
https://bookmarkbirth.com/story15878475/syphilis-market
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9193216187
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/stem-cell-market
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Glaucoma Competitive Landscape Report (Updated) | Santen Pharmaceuticals, Visiox Pharma, Nicox Ophthalmics, pH Pharma, Omikron Italia, Tarsier Pharma, AbbVie, and others. here
News-ID: 3350647 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Glaucoma
Glaucoma Surgery Devices Market Report 2024 - Glaucoma Surgery Devices Market Si …
"The Business Research Company recently released a comprehensive report on the Global Glaucoma Surgery Devices Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The glaucoma surgery devices…
Global Glaucoma Market
According to a new market research report published by Global Market Estimates, the Global Glaucoma Market is projected to grow at a CAGR value of 5.0% from 2023 to 2028.
Growing awareness for early diagnosis of glaucoma have gained prominence due to various educational campaigns and screening programs. Early detection allows for timely intervention, leading to better disease management and reducing the risk of vision loss, thus propelling the market growth.…
Glaucoma Treatment Market - Safeguarding Sight: Innovating Glaucoma Treatment fo …
Newark, New Castle, USA: The "Glaucoma Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Glaucoma Treatment Market: https://www.growthplusreports.com/report/glaucoma-treatment-market/8926
This latest report researches the industry structure, sales, revenue,…
Glaucoma Surgical Devices Market By Device Type (Glaucoma Drainage Devices, Impl …
Glaucoma Surgical Devices market report presents a global overview of market shares, size, statistics, trends, demand, revenue and growth opportunities by key players, regions and countries. This report offers a complete market overview during the past, present, and the forecast period till 2032 which helps to identify future opportunities, risk factors, growing areas. Report also highlight on recent developments, technological innovations, market affecting factors, demographics analysis, demand and supply chain…
Micro-Invasive Glaucoma Implants Micro-Invasive Glaucoma Implants
Global Micro-Invasive Glaucoma Implants Market Definition: Micro-invasive glaucoma implants is performed for the treatment of the open- angle glaucoma and is done through an ab- interno approach. It is very safe and provides faster recovery as compared to the traditional methods. They usually lower the intraocular by increasing the flow or reducing the production of the aqueous humor. Increasing cases of the glaucoma worldwide is the major factor fueling the…
Glaucoma Surgery Devices Market 2016: Glaucoma Systems, Glaucoma Laser Devices
Latest industry research report on Glaucoma surgery devices are used in the glaucoma treating procedure. These procedures include both surgical and laser therapies performed on a patient. The cases of blindness due to glaucoma is on rise across the several countries. Furthermore, the demand for both technologically as well as advanced surgical equipment has resulted in the popularity of glaucoma surgery devices industry, worldwide.
Sudden increase in the aging population and…
